Specifically, there are three main aspects to present: hypercalcemia that causes pancreatitis amid these parathyroid tumors, pancreatic and parathyroid NETs’ co-presence, and the pancreas’s involvement as an essential contributor to insulin resistance that is identified in subjects with primary hyperparathyroidism. This evidence concerns the gene INS and hypercalcemia disease.